Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Masitinib mesylate application for conditional approval
Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination.
Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis.
The quality of reports of randomized trials in multiple sclerosis: a review.
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.
High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.
Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor kcyB (NF-kcyB) and Extracellular Signal-regulated kinase 1 and 2 (ERK1/2) and Mitogen Stress activated kinase 1 (MSK1) signaling.
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.
Delta-9-tetrahydrocannabinol/cannabidiol (sativex(®)): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Multiple sclerosis, vitamin D, and HLA-DRB1*15.
Teva announces U.S. FDA approval of three-times-a-week COPAXONE® (glatiramer acetate injection) 40mg/mL
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.
Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.
Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity.
Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population.
Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice.

Pages